HC Wainwright & Co. Maintains Buy on Eton Pharmaceuticals, Raises Price Target to $70

Benzinga · 2d ago
HC Wainwright & Co. analyst Swayampakula Ramakanth maintains Eton Pharmaceuticals (NASDAQ:ETON) with a Buy and raises the price target from $65 to $70.